Type 1 diabetes research: Newer approaches and exciting developments
- PMID: 20142867
- PMCID: PMC2812749
- DOI: 10.4103/0973-3930.53119
Type 1 diabetes research: Newer approaches and exciting developments
Conflict of interest statement
Similar articles
-
Future therapeutic directions; new medications and insulin delivery in a changing world for effective diabetes management.Curr Drug Discov Technol. 2009 Sep;6(3):200-13. doi: 10.2174/157016309789054951. Epub 2009 Sep 1. Curr Drug Discov Technol. 2009. PMID: 19496750 Review.
-
Intensifying Treatment Beyond Monotherapy in Type 2 Diabetes Mellitus: Where Do Newer Therapies Fit?Curr Cardiol Rep. 2017 Mar;19(3):25. doi: 10.1007/s11886-017-0832-3. Curr Cardiol Rep. 2017. PMID: 28251513 Review.
-
Psychiatry in the 21st century: evolving diagnostic and therapeutic strategies.N J Med. 1993 Feb;90(2):111-2. N J Med. 1993. PMID: 8464573
-
Multiagonist Unimolecular Peptides for Obesity and Type 2 Diabetes: Current Advances and Future Directions.Clin Med Insights Endocrinol Diabetes. 2020 Feb 14;13:1179551420905844. doi: 10.1177/1179551420905844. eCollection 2020. Clin Med Insights Endocrinol Diabetes. 2020. PMID: 32110131 Free PMC article. Review.
-
Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.Drugs. 2004;64(22):2537-65. doi: 10.2165/00003495-200464220-00004. Drugs. 2004. PMID: 15516153 Review.
References
-
- Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G. EURODIAB Study Group. Incidence trends for childhood diabetes in Europe during 1989 to 2003. Lancet. 2009;373:2027–33. - PubMed
LinkOut - more resources
Full Text Sources